Alexandria Real Estate Equities, Inc. Announces Early Results and Upsizing of Cash Tender Offers

Core Viewpoint - Alexandria Real Estate Equities, Inc. has announced early results and an increase in the cash tender offers for its outstanding senior notes, indicating strong interest from investors and a strategic move to manage its debt effectively [1]. Group 1: Tender Offer Details - The company is conducting cash tender offers for three series of senior notes: 3.000% Senior Notes due 2051, 3.550% Senior Notes due 2052, and 4.000% Senior Notes due 2050 [1]. - As of February 9, 2026, the company received valid tenders totaling $497.602 million for the 2051 Notes, $524.594 million for the 2052 Notes, and $309.199 million for the 2050 Notes [1]. - The aggregate principal amount of all notes validly tendered by the Early Tender Date equals the Aggregate Maximum Tender Amount, leading the company to not expect any additional tenders after this date [1]. Group 2: Financial Management - The company is increasing the Aggregate Maximum Tender Amount to accept all validly tendered notes, demonstrating a proactive approach to managing its debt obligations [1]. - The determination of the Total Consideration for the tender offers will occur on February 10, 2026, indicating a structured timeline for the transaction [1]. - The company has engaged multiple financial institutions as Lead Dealer Managers and Co-Dealer Managers for the tender offers, showcasing a robust support structure for the transaction [1]. Group 3: Company Background - Alexandria Real Estate Equities, Inc. is a leading life science REIT, recognized for its pioneering role in the life science real estate sector since its founding in 1994 [2]. - The company operates in key life science innovation clusters, including Greater Boston, San Francisco Bay Area, and New York City, positioning itself as a significant player in the industry [2].